Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

AV45-A11 Study Group, Doraiswamy, P M, Sperling, R A, Johnson, K, Reiman, E M, Wong, T Z, Sabbagh, M N, Sadowsky, C H +8 more·2014·Molecular Psychiatry

DOI 10.1038/mp.2014.9

Cited by (185)

Items 101–185 of 185

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline
Helen M. Hochstetler, Alzheimer’s Disease Neuroimaging Initiative, Paula T. Trzepacz, Shufang Wang, Peng Yu, Michael G. Case, David B. Henley, Elisabeth K. Degenhardt, Jeannie‐Marie Leoutsakos, Constantine George Lyketsos · 2016 · Journal of Alzheimer s Disease
Neurons derived from individual early Alzheimer’s disease patients reflect their clinical vulnerability
Bryan Ng, Helen A. Rowland, Tina Wei, Kanisa Arunasalam, Emma Mee Hayes, I. Koychev, A. Hedegaard, Elena M. Ribe, Dennis Chan, Tharani Chessell et al. · 2022 · Brain Communications
Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach
H. Geerts, A. Spiros · 2020 · Alzheimer's & Dementia
Advances in neuroimaging to support translational medicine in dementia
T. E. Cope, R. Weil, E. Düzel, B. Dickerson, J. Rowe · 2021 · Journal of Neurology Neurosurgery & Psychiatry
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
Nancy Nairi Maserejian, Shijia Bian, Wenting Wang, Judith Jaeger, Jeremy A. Syrjanen, Jeremiah A. Aakre, Clifford R. Jack, Michelle M. Mielke, Feng Gao · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Spontaneous Reversion of Clinical Conditions Measuring the Risk Profile of the Individual: From Frailty to Mild Cognitive Impairment
M. Canevelli, G. Bruno, F. Remiddi, C. Vico, E. Lacorte, N. Vanacore, M. Cesari · 2017 · Frontiers in Medicine
Early and Late Pathomechanisms in Alzheimer’s Disease: From Zinc to Amyloid-β Neurotoxicity
Andrzej Szutowicz, Hanna Bielarczyk, Marlena Zyśk, Aleksandra Dyś, Anna Ronowska, Sylwia Gul‐Hinc, Joanna Klimaszewska‐Łata · 2016 · Neurochemical Research
Advanced imaging of tau pathology in Alzheimer Disease: New perspectives from super resolution microscopy and label‐free nanoscopy
Gabriele S. Kaminski Schierle, Claire H. Michel, Laura Gasparini · 2016 · Microscopy Research and Technique
Impact of Resilience on the Association Between Amyloid-β and Longitudinal Cognitive Decline in Cognitively Healthy Older Adults
Dominik Georg Friedrich Wolf, Alzheimer’s Disease Neuroimaging Initiative, Florian U. Fischer, Andreas Fellgiebel · 2019 · Journal of Alzheimer s Disease
AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer’s Disease
H. Bielarczyk, Agnieszka Jankowska-Kulawy, Corinna Höfling, A. Ronowska, S. Gul-Hinc, S. Roßner, R. Schliebs, T. Pawełczyk, A. Szutowicz · 2015 · Journal of Alzheimer's Disease
Proactive Semantic Interference Is Associated With Total and Regional Abnormal Amyloid Load in Non-Demented Community-Dwelling Elders: A Preliminary Study
D. Loewenstein, M. Greig, R. Curiel, R. Rodriguez, M. Wicklund, W. Barker, Jacqueline Hidalgo, M. Rosado, R. Duara · 2015 · The American journal of geriatric psychiatry
Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial
M. Lilamand, M. Cesari, C. Cantet, P. Payoux, S. Andrieu, B. Vellas · 2018 · Journal of The American Geriatrics Society
Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C]PBT2
Hema S. Krishnan, Vadim Bernard‐Gauthier, Michael S. Placzek, Kenneth Dahl, Vidya Narayanaswami, Elijahu Livni, Zhen Chen, Jing Yang, Thomas Lee Collier, Chongzhao Ran et al. · 2018 · Molecular Pharmaceutics
Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
Alzheimer’s Disease Neuroimaging Initiative, Konstantinos Chiotis, Stephen F. Carter, Karim Farid, Irina Savitcheva, Agneta K. Nordberg · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
Deep learning model for individualized trajectory prediction of clinical outcomes in mild cognitive impairment
Wonsik Jung, Si Eun Kim, Jun Pyo Kim, Hyemin Jang, Chae Jung Park, H. Kim, Duk L. Na, S. W. Seo, Heung-Il Suk · 2024 · Frontiers in Aging Neuroscience
Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using Amyloid PET and Brain MR Imaging Data: A 48-Month Follow-Up Analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort
Do-Hoon Kim, Minyoung Oh, Jae Seung Kim · 2023 · Diagnostics
Genome-wide association study identifies susceptibility loci of brain atrophy to NFIA and ST18 in Alzheimer's disease
Bo-Hyun Kim, Kwangsik T. Nho, Jong‐Min Lee · 2021 · Neurobiology of Aging
Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis
Jet M. J. Vonk, Emma L. Twait, Rob J. P. M. Scholten, Mirjam I. Geerlings · 2020 · Mechanisms of Ageing and Development
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
M. Rullmann, A. McLeod, M. Grothe, O. Sabri, H. Barthel · 2020 · Journal of Nuclear Medicine
Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database
F. Ben Bouallègue, F. Vauchot, D. Mariano-Goulart, P. Payoux · 2018 · Brain Imaging and Behavior
Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta
Tatiana Karelina, Oleg O Demin, Oleg O Demin, Sridhar Duvvuri, Timothy Nicholas · 2017 · CPT Pharmacometrics & Systems Pharmacology
Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
Elizabeth A. Dao, Ging‐Yuek Robin Hsiung, Vesna Sossi, Claudia Jacova, Roger C. Tam, Katie Dinelle, John R. Best, Teresa Y L Liu-Ambrose · 2015 · BMC Neurology
18F-FDG-PET and Multimodal Biomarker Integration: A Powerful Tool for Alzheimer’s Disease Diagnosis
Yvonne Bouter, Robert M. Glasnek, Joerg Wenzel, Caroline Bouter · 2025 · Nuclear Medicine and Molecular Imaging
Can Brief Cognitive or Medication Management Tasks Identify the Potential for Dependence in Instrumental Activities of Daily Living?
Timothy S. Marks, Gordon Muir Giles, Muhammad O. Al‐Heizan, Dorothy Farrar Edwards · 2020 · Frontiers in Aging Neuroscience
Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals
Michael Malek-Ahmadi, Ke-Wei Chen, Sylvia E. Perez, E. Mufson · 2018 · Journal of Alzheimer's Disease
Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia
David A. Weidman, EDWARD Y. ZAMRINI, Marwan Noel Sabbagh, Sandra A. Jacobson, Anna D Burke, Christine M. Belden, Jessica J. Powell, Nidhi Bhalla, Auttawut Roontiva, Xiaoying Kuang et al. · 2017 · Neurocase
Impact of Amyloid Pathology in Mild Cognitive Impairment Subjects: The Longitudinal Cognition and Surface Morphometry Data
Hsin-I Chang, Shih-Wei Hsu, Zih-Kai Kao, Chen-Chang Lee, Shu-Hua Huang, Ching-Heng Lin, Mu-N. Liu, Chiung-Chih Chang · 2022 · International Journal of Molecular Sciences
Molecular PET Imaging in Alzheimer’s Disease
Tanyaluck Thientunyakit, Shuichi Shiratori, Kazunari Ishii, Juri George Gelovani · 2022 · Journal of Medical and Biological Engineering
Prediction of tau accumulation in prodromal Alzheimer’s disease using an ensemble machine learning approach
Jaeho Kim, Y. Park, Seongbeom Park, Hyemin Jang, H. Kim, D. Na, Hyejoo Lee, S. Seo · 2021 · Scientific Reports
Efficacy and neural mechanism of acupuncture treatment in older adults with subjective cognitive decline: study protocol for a randomised controlled clinical trial
Chao-Qun Yan, Ping Zhou, Xu Wang, Jian-Feng Tu, Shang-Qing Hu, Jian-Wei Huo, Zhongyan Wang, Guang-Xia Shi, Ya-Nan Zhang, Junqing Li et al. · 2019 · BMJ Open
PET amiloide en enfermedades neurodegenerativas que cursan con demencia
Valle Camacho, Adolfo Gómez‐Grande, Pablo Sopeña, David García-Solís, M. Gómez Río, Carles Lorenzo‐Bosquet, Sebastià Rubí, Javier Arbizu · 2018 · Revista Española de Medicina Nuclear e Imagen Molecular
Alzheimer's Disease: An Overview of Recent Developments and a Look to the Future.
Alice Uflacker, P. M. Doraiswamy · 2017 · Focus
Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories
S. Ackley, E. Hayes-Larson, Willa D. Brenowitz, Kaitlin N. Swinnerton, D. Mungas, E. Fletcher, Baljeet Singh, R. Whitmer, C. Decarli, M. Glymour · 2021 · NeuroImage: Clinical
Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer’s Disease
Sung-Min Jun, Heeyoung Kim, B. Kim, B. Yoo, Won Gu Lee, Alzheimer's Disease Neuroimaging Initiative · 2019 · Journal of Alzheimer's Disease
Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project
McCluskey, Georgia E., Yates, Paul, Villemagne, Victor L., Rowe, Christopher, Szoeke, Cassandra E. I. · 2018 · Brain Imaging and Behavior
Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?
Balaji Kannappan, Jan Te Nijenhuis, Yu-Yong Choi, J. Lee, Kyu Yeong Choi, Irena Balzekas, H. Jung, Y. Choe, Min-Kyung Song, Ji Y. Chung et al. · 2022 · PLoS ONE
Network-constrained technique to characterize pathology progression rate in Alzheimer’s disease
Fon Powell, Duygu Tosun, Ashish Raj, Alzheimer’s Disease Neuroimaging Initiative · 2021 · Brain Communications
Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer’s Disease
José V. Pardo, Joel T. Lee, Alzheimer’s Disease Neuroimaging Initiative · 2018 · eNeuro
The Genetics of Amyloid Deposition: A Systematic Review of Genome-Wide Association Studies Using Amyloid PET Imaging in Alzheimer’s Disease
A. Amanullah, Melika Mirbod, A. Pandey, S. B. Singh, Om H. Gandhi, Cyrus Ayubcha · 2025 · Journal of Imaging
Online awareness is associated with superior performance on assessments of functional cognition
Timothy S. Marks, G. Giles, Dorothy Farrar Edwards · 2024 · Frontiers in Aging Neuroscience
Cognitive Trajectories in Preclinical and Prodromal Alzheimer’s Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach
S. Teipel, M. Dyrba, Fedor Levin, S. Altenstein, M. Berger, Aline Beyle, F. Brosseron, K. Buerger, L. Burow, L. Dobisch et al. · 2023 · Journal of Alzheimer's disease reports
Aducanumab: an uprising hope with vague horizons
Delara Hazegh Fetratjoo, Alireza Kargar, Maryam Noroozıan · 2023 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
Loss-of-Set and Strategy Application on the Menu Task: An Exploratory Study
G. Giles, Timothy S. Marks, D. F. Edwards · 2023 · Canadian journal of occupational therapy. Revue canadienne d'ergotherapie
Fingerprints of brain disease: Connectome identifiability in cognitive decline and Alzheimer’s disease
Sara Stampacchia, Saina Asadi, Szymon Tomczyk, F. Ribaldi, M. Scheffler, K. Lövblad, M. Pievani, Aïda B. Fall, M. G. Preti, Paul G. Unshuld et al. · 2022 · bioRxiv
The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus: A pooled analysis.
D. Mallon, P. Malhotra, M. Naik, P. Edison, R. Perry, C. Carswell, Z. Win · 2021 · Journal of clinical neuroscience
Neuroimaging Findings in Mild Cognitive Impairment
Flavio Mariano Nobili, Dario Arnaldi, Luca Roccatagliata, A. Chincarini, Jennifer Accardo, Agnese Picco, Michela Ferrara, Ambra Buschiazzo, Silvia Daniela Morbelli · 2014 · Springer eBooks
Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease
Tanyaluck Thientunyakit, Chakmeedaj Sethanandha, Weerasak Muangpaisan, Orasa Chawalparit, Kuntarat Arunrungvichian, Tossaporn Siriprapa, Thonnapong Thongpraparn, Rujaporn Chanachai, Juri George Gelovani · 2018 · Nuclear Medicine Communications
The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.
S. Kollack-Walker, Collin Y. Liu, A. Fleisher · 2017 · Neurologic clinics
Aberrant brain stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer’s disease
Ji-Han Lee, W. Jung, W. Choi, H. Lim · 2016 · Neuropsychiatric Disease and Treatment
In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease
Jing Cui, Valérie Zufferey, Ferath Kherif · 2015 · Current Opinion in Neurology
Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series.
Olga G. James, Alexandra R. Linares, C. Hellegers, P. Doraiswamy, T. Wong · 2021 · Clinical Nuclear Medicine
Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer’s Disease: Results from the Gothenburg H70 Birth Cohort Studies
Maya Arvidsson Rådestig, Johan Skoog, Henrik Zetterberg, Jürgen Kern, Anna Zettergren, Simona F. Sacuiu, Margda Wærn, Hanna Wetterberg, Kaj Blennow, Ingmar Gr. Skoog et al. · 2020 · Journal of Alzheimer s Disease
Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians.
N. Del Campo, M. Cesari, M. Canevelli, E. Hoogendijk, M. Lilamand, E. Kelaiditi, M. Soto, P. Ousset, M. Weiner, S. Andrieu et al. · 2016 · Journal of the American Medical Directors Association
Multilayer Clustering: Biomarker Driven Segmentation of Alzheimer's Disease Patient Population
D. Gamberger, B. Ženko, Alexis Mitelpunkt, N. Lavrač · 2015 · International Work-Conference on Bioinformatics and Biomedical Engineering
Comparison of accumulation rates of beta-amyloid tracers and their relationship with cognitive changes
Soo Hyun Cho, Heekyoung Kang, H. Ham, Seung Hwan Moon, Hyemin Jang, J. Yun, Eun Hye Lee, Daeun Shin, S. Yim, Byeong C. Kim et al. · 2025 · Scientific Reports
Simplifying Alzheimer’s Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire
Kenichiro Sato, Yoshiki Niimi, R. Ihara, Kazushi Suzuki, A. Iwata, T. Iwatsubo · 2024 · Journal of Alzheimer's Disease
Diagnostic de la maladie d’Alzheimer : apport de l’imagerie au florbétapir et autres radiopharmaceutiques de la plaque amyloïde
Franck Semah, Walter G. Deberdt, Mathieu Pierre Ceccaldi · 2016 · Médecine Nucléaire
Advances in Retinal Imaging: Retinal Amyloid Imaging
Maya Koronyo‐Hamaoui, Jonah Doustar, Mia Oviatt, Keith L. Black, Yosef Koronyo · 2020 · Springer eBooks
Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology
B. Plassman, Cassie B. Ford, Valerie A. Smith, Nicole DePasquale, James R. Burke, Laura E. Korthauer, Brian R. Ott, Emmanuelle Bélanger, M. Shepherd-Banigan, E. Couch et al. · 2024 · Journal of Alzheimer's Disease
Estimated Wasteful Spending on Aducanumab Dispensing in the U.S. Medicare Population: A Cross-Sectional Analysis
C. Oronce, J. Arbanas, M. Leng, B. Landon, C. Damberg, C. Sarkisian, J. Mafi · 2022 · Journal of The American Geriatrics Society
Erratum to: Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
Elizabeth Dao, G. Hsiung, V. Sossi, C. Jacova, R. Tam, K. Dinelle, J. Best, T. Liu-Ambrose · 2016 · BMC Neurology
Assessing the Preparedness of the Australian Health Care System Infrastructure for an Alzheimer's Disease-Modifying Therapy
S. Baxi, F. Girosi, Jodi L. Liu · 2019 · RAND Corporation eBooks
The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer’s Disease
Alexander Kurz, Nicola T. Lautenschlager · 2018 · Neuromethods
Utility of the Seoul Cognitive Status Test to detect amyloid status in mild cognitive impairment
Hasom Moon, Young Ju Kim, S. W. Seo, J. Shin, Duk L. Na, Juhee Chin, Hyemin Jang · 2025 · Journal of Alzheimer's Disease
Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort.
S. Ackley, Camilla Calmasini, V. Bouteloup, T. Hill-Jarrett, Kaitlin N. Swinnerton, G. Chêne, C. Dufouil, M. Glymour · 2024 · Neurology
Amyloid PET in neurodegenerative diseases with dementia
Valle Camacho, Adolfo Gómez‐Grande, P. Sopena, David García Solís, M. Gómez Río, Carles Lorenzo‐Bosquet, Sebastià Rubí, Javier Arbizu · 2018 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Recognizing common PET patterns in neurodegenerative dementia
Yin-Jie Chen, J. Dubroff, I. Nasrallah · 2017 · Applied Radiology
Amyloid Imaging in Dementia and Related Disorders
Valle Camacho, Ignasi Carrió · 2016 · Springer eBooks
Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.
Simone Lista, L. Filippi, Enzo Emanuele, S. López-Ortiz, Giusy Ylenia Cisale, P. Minoretti, F. Garaci, Alejandro Santos-Lozano · 2026 · Molecular Diagnosis & Therapy
PET-based molecular imaging in neurodegeneration and dementia: current and emerging radiotracers
Nelson Gil, Priyanka Naik, Mary Ellen Koran, Daniel Silverman, Bashar Kako, John Chen · 2026 · Radiology Advances
[18F]Florapronol (Alzavue®) Amyloid Burden and 4-Year [18F]FDG Metabolic Neurodegeneration in Amnestic Mild Cognitive Impairment
Su Yeon Park, Inki Lee, I. Lim, Byung Il Kim, D. Chi, Byeong Hyeon Byeon, J. Ha · 2026 · Nuclear medicine and molecular imaging
Menu Task scores parallel impairment group categorization on the Montreal Cognitive Assessment
Timothy S. Marks, G. Giles, D. Edwards · 2026 · Archives of Rehabilitation Research and Clinical Translation
Cognitive performance and blood biomarkers: Insights into their relationship and predicting high Amyloid Probability Score in cognitively impaired older adults
Thi Quynh Tho Chu, Kohei Morimoto, Hisatomo Kowa · 2025 · Journal of Alzheimer's Disease
[Phantom Study for Amyloid and Tau PET Imaging].
Kei Wagatsuma, K. Miwa, Y. Kamitaka, Tensho Yamao, Go Akamatsu, Shohei Fukuda, M. Sakata, Noriaki Miyaji, K. Ishii · 2024 · Nihon Hōshasen Gijutsu Gakkai zasshi
Intelligent diagnosis strategies of Alzheimer's disease
Bo Li, Yixin Cui · 2024 · International Conference on Biomedical and Intelligent Systems
Neurons from individual early Alzheimer’s disease patients reflect their clinical vulnerability
Bryan Ng, H. Rowland, Tina Wei, Kanisa Arunasalam, Emma Mee Hayes, I. Koychev, A. Hedegaard, Elena M. Ribe, D. Chan, Tharani Chessell et al. · 2021 · bioRxiv
Plasma miRNAs as Biomarkers for Amnestic Mild Cognitive Impairment and Modulation on BACE1
Haining He, Huanqing Yang, Wei Zhang, Zuoquan Xie, Minmin Zhang, Hua Xu, Yuanyuan Liu, Na An, Bo Hong, Feng Yan et al. · 2020
Progression of Treating Alzheimer’s Disease with Stem Cell-based Therapies
Jigishu Ahmed, Hafizur Rahman · 2019 · International Annals of Science
Imagerie métabolique et moléculaire : l’exemple des maladies neurodégénératives
A. Gabelle · 2018 · Bulletin de l'Académie Nationale de Médecine
Les modifications du sommeil et du cycle veille/sommeil au cours du vieillissement : approche par actimétrie et imagerie cérébrale
Marion Baillet · 2017 · theses.fr (ABES)
Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
Malak Itani, Burcak Yilmaz Gunes, G. Akaike, F. Behnia · 2017 · Radiology Case Reports
3D printing of beta-amyloid protein deposits along capillary walls
China Blue, Seth S. Horowitz, Peter Jeffrey Snyder · 2017 · Journal of Biomedical Graphics and Computing
Prädiktor des kognitiven Funktionsverlusts
C. Lange-Asschenfeldt · 2014 · InFo Neurologie & Psychiatrie
How to improve success rates of the compounds acting on CNS using biomarkers.
S. Katsumata · 2017 · Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Molecular Imaging in Alzheimer Clinical Trials
Mark E. Schmidt, Dawn C. Matthews, Steven G. Staelens · 2016 · Elsevier eBooks